73742-45-7

• 常用中文名：5-氯-6-(氯甲基)-2,4(1H,3H)-嘧啶二酮
• 常用英文名：5-Chloro-6-(chloromethyl)-2,4(1H,3H)-pyrimidinedione
• CAS号：73742-45-7
• 分子式：C₅H₄Cl₂N₂O₂
• 分子量：195.00300
• 发布时间：2018-12-24 08:44:00
• 更新时间：2024-01-12 22:27:11

名称

• 中文名: 5-氯-6-(氯甲基)-2,4(1h,3h)-嘧啶二酮
• 英文名: 5-chloro-6-(chloromethyl)-1H-pyrimidine-2,4-dione
• 英文别名: 5-chloro-6-chloromethyl-1H-pyrimidine-2,4-dione; 5-Chloro-6-(chloromethyl)pyrimidine-2,4(1H,3H)-dione; 5-Chlor-6-chlormethyl-1H-pyrimidin-2,4-dion; 5-chloro-6-chloromethyluracil; 5-chloro-6-(chloromethyl)-2,4-dihydroxypyrimidine

物化性质

• 密度: 1.63g/cm3
• 分子式: C₅H₄Cl₂N₂O₂
• 分子量: 195.00300
• 精确质量: 193.96500
• PSA: 65.72000
• LogP: 0.45540
• 折射率: 1.583
• 储存条件: 2-8℃，惰性气体保存

安全

• 危害码 (欧洲): T+
• 海关编码: 2933599090

合成路线

18592-13-7 ~91% 73742-45-7

文献：Taiho Charmaceutical Co., Ltd. Patent: US6255314 B1, 2001 ;

626-48-2 ~% 73742-45-7

文献：Johnson Journal of the American Chemical Society, 1943 , vol. 65, p. 1220 Journal of the American Chemical Society, 1944 , vol. 66, p. 146

36327-91-0 ~% 73742-45-7

文献：Sun, Lingyi; Li, Jiarong; Bera, Hriday; Dolzhenko, Anton V.; Chiu, Gigi N.C.; Chui, Wai Keung European Journal of Medicinal Chemistry, 2013 , vol. 70, p. 400 - 410

22126-44-9 ~% 73742-45-7

文献：Sun, Lingyi; Li, Jiarong; Bera, Hriday; Dolzhenko, Anton V.; Chiu, Gigi N.C.; Chui, Wai Keung European Journal of Medicinal Chemistry, 2013 , vol. 70, p. 400 - 410

7647-01-0 50610-49-6 ~% 73742-45-7

文献：Cornforth; Huang Journal of the Chemical Society, 1948 , p. 1988

50610-49-6 ~% 73742-45-7

文献：Cornforth; Huang Journal of the Chemical Society, 1948 , p. 1988 Show Details Johnson Journal of the American Chemical Society, 1943 , vol. 65, p. 1220 Journal of the American Chemical Society, 1944 , vol. 66, p. 146

上下游产品

上游产品  6
18592-13-7 50610-49-6 626-48-2 36327-91-0
22126-44-9 7647-01-0
下游产品  1
16018-87-4

海关

海关编码	2933599090
中文概述	2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%